IL1B and COVID-19: Whereas a relatively low spontaneous production of some cytokines is observed in monocytes of COVID-19 patients with hyper-inflammation versus controls and in patients with sepsis, additional LPS stimulation caused a strong further enhancement of expression of all cytokines (especially of interleukin [IL]-1β) in COVID-19, but not in septic patients.